BIOC Insider Trading Activity and SEC Form 4 Filings
BIOC insider trading summary
No open-market insider purchases or sales of Biocept Inc (BIOC) have been reported on SEC Form 4 in the past 12 months.
Latest BIOC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 9, 2021 | David F Hale | Director | Sell | $289 (71 @ $4.07) |
| Dec 9, 2021 | David F Hale | Director | Sell | $1K (363 @ $4.06) |
| Dec 9, 2021 | David F Hale | Director | Sell | $45 (11 @ $4.07) |
| Jun 12, 2020 | David F Hale | Director | Sell | $247 (445 @ $0.55) |
| Jun 12, 2020 | David F Hale | Director | Sell | $89 (159 @ $0.56) |
| Jun 12, 2020 | David F Hale | Director | Sell | $309 (556 @ $0.56) |
| Jan 30, 2018 | Bruce Gerhardt | Director | Buy | $0 (25,000 @ $0.00) |
| Oct 19, 2016 | David F Hale | Director | Buy | $100K (90,909 @ $1.10) |
| Oct 19, 2016 | Claire Reiss | 10% Owner | Buy | $250K (227,272 @ $1.10) |
| Oct 19, 2016 | Bruce Gerhardt | Director | Buy | $55K (50,000 @ $1.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.